Alteration of the metabolism of membrane phospholipids in Alzheimer's disease;RELEVANZ DES METABOLISMUS DER MEMBRANPHOSPHOLIPIDE FUR DIE ALZHEIMER-DEMENZ

Fortschritte der Neurologie Psychiatrie

Volumn 64, Issue 1, 1996, Pages 8-12

  Gattaz, W F ^a,c   Levy, R ^b   Cairns, N J ^b   Forstl H ^a   Braus, D F ^a   Maras, A ^a  

^a Zentralinstitut F Seelische G   (Germany)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c Zentralinstitut F Seehsche G   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOLIPASE A2; PHOSPHOLIPID;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; METABOLISM; NEUROFIBRILLARY TANGLE; SENILE PLAQUE; THROMBOCYTE;

EID: 0030022794     PISSN: 07204299     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-996367     Document Type: Article

References (42)

1. Bárány, M., Y C. Chang, C. Arús, T. Rustan, W. H. Frey: Increased glycerol-3-phosphorylcholine in post-mortem Alzheimer's brain. Lancet 1 (1985) 517
2. Bazan, H E. P., B. Ridenour, D. L. Birkle, N. G. Bazan: Unique metabolic features of docosahexanoate metabolism related to functional roles in brain and retina. In: Horroks, L. A., L. Freysz, G. Toffano (eds.): Phospholipid research and the nervous system. Biochemical and molecular pharmacology. Fidia Research Series, vol. 4, Liviana Press, Padova (1986) pp 67-78
3. Blusztajn, J. K., M. Liscovitch, U. I. Richardson: Synthesis of acetylcholine from choline derived from phosphatidylcholine in a human neuronal cell line. Proc. Natl. Acad. Sci. USA 84 (1987) 5474
4. Blusztajn, J. K., R. J. Wurtman: Choline and cholinergic neurons. Science 221 (1983) 614-620
5. 31P NMR profiles of Alzheimer's disease and multiple subcortical infarct dementia. Neurology 39 (1989) 1423-1427
6. Caporaso, G. L., S. E. Gandy, J. D. Buxbaum, T. V. Ramabhadran, P. Greengard: Protein phosphorylation regulates secretion of Alzheimer βA4 amyloid precursor protein. Proc. Natl. Acad. Sci. USA 89 (1992) 3055-3059
7. 31Phosphorus magnetic resonance spectroscopy of the frontal and parietal Lobes in chronic schizophrenia. Biol. Psychiatry 36 (1994) 503-510
8. Deicken, R. F., E. L. Merrin, T. C. Floyd, M. W. Weiner: Correlation between left frontal phospholipids and Wisconsin Card Sort test performance in schizophrenia. Schizophrenia Res. 14 (1995) 177
9. Ellison, D. W., M. F. Beal, J. B. Martin: Phosphoethanolamine and ethanolamine are decreased in Alzheimer's disease and Huntington's disease. Brain Res. 417 (1987) 389-392
10. 2 activation influences the processing and secretion of the amyloid precursor protein. Biochem. Biophys. Res. Commun. 197 (1993) 292-297
11. Farooqui, A. A., Y. Hiroshima, L. A. Horrocks: Brain phospholipases and their role in signal transduction. In: Bazan, N. G., G. Toffano, M. Murphy (eds.): Neurobiology of Essential Fatty Acids. Plenum Press, New York (1992) pp 11-25
12. Fukushima, D., M. Konishi, K. Maruyama, T. Miyamoto, S. Ishiura, K. Suzuki: Activation of the secretory pathway leads to a decrease in the intracellular amyloidogenic fragments generated from the amyloid protein precursor. Biochem. Biophys. Res. Commun. 194 (1993) 202-207
13. 2 activity in schizophrenia. Reduction after neuroleptic therapy. Biol. Psychiatry 22 (1987) 421
14. 2 an der Pathogenese der Schizophrenie. Fortschr. Neurol. Psychiat. 58 (1990a) 148-153
15. 2 activity in schizophrenia: a replication study. Biol. Psychiatry 28 (1990b) 495-501
16. Gattaz, W. F., J. Brunner, A. Schmitt, A. Maras: Beschleunigter Abbau von Membranphospholipiden bei der Schizophrenie: Implikationen für die Hypofrontalitätshypothese. Fortschr. Neurol. Psychiat. 62 (1994) 489-496
17. 2 activity in schizophrenia. Schizophrenia Res. 16 (1995a) 1-6
18. 2 activity in Alzheimer brains. Biol. Psychiatry 37 (1995b) 13-17
19. 2 activity in patients with Alzheimer Dementia compared to healthy and psychiatric controls. (zur Veröffentlichung vorgelegt), 1995c
20. Haass, C., M. G. Schlossmacher, A. Y. Hung, C. Vigo-Pelfrey, A. Mellon, B. L. Ostaszewski, I. Lieberburg, E. H Koo, D Schenk, D. B. Teplow, D. J. Selkoe: Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 359 (1992) 322-325
21. Haass, C., D. J. Selkoe: Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide. Cell 75 (1993) 1039
22. Harrison, P.: Alzheimer's disease and chromosome 14: Different Gene, same process? Brit. J. Psychiatry 163 (1993) 2-5
23. Hirata, F., G. Axelrod: Phospholipid methylation and biological signal transmission. Science 209 (1980) 1082-1090
24. 2 produce amnesia for a passive avoidance task in the chick. Behav. Neural. Biology 61 (1994) 225-232
25. Huebner, K., L. A. Cannizzaro, A. Z. Frey, B. K. Hecht, F. Hecht, C. M. Croce, B. P. Wallner: Chromosomal localization of the human genes for lipocortin I and lipocortin II. Oncogene Res. 2 (1988) 299
26. Hung, A. Y., C. Haass, R. M. Nitsch, W Q Qiu, M. Citron, R. J. Wurtman, J. H. Growdon, D. J. Selkoe. Activation of protein kinase C inhibits cellular production of the amyloid β-protein. J. Biol. Chem. 268 (1993) 22959-22962
27. 2 genes and two related genetic elements. Adv. Exp. Med. Biol. 275 (1990) 17-34
28. Kanfer, J. N., H. Hattori, D. Orihel: Reduced phospholipase D activity in brain tissue samples from Alzheimer's disease patients. Ann. Neurol. 20 (1986) 265-267
29. 2(s); comparison of arachidonyl-selective and -nonselective enzymes. FASEB Journal 7 (1993) 339-348
30. 4 precursor protein by stimulated human peripheral blood leucocytes. FEBS 277 (1990) 261-266
31. Nitsch, R. M., J. K. Blusztajn, J. K , A. G. Pittas, B. E. Slack, J H. Growdon, R. J. Wurtman: Evidence for a membrane defect in Alzheimer disease brain. Proc. Natl. Acad. Sci. USA 89 (1992) 1671-1675
32. 2 activity in schizophrenics and other psychiatric patients. Biol. Psychiatry 34 (1993) 641-649
33. Nostrand, W. E van, A. H Schmaier, J S Farrow, D. D. Cunningham: Protease nexin-II (amyloid β-protein precursor): a platelet β-granule protein. Science 248 (1990) 745-748
34. Pangerl, A. A., A. Steudle, H. W. Jaroni, W. F. Gattaz: Increased platelet membrane lysophosphatidylcholine in schizophrenia. Biol. Psychiatry 30 (1991) 837-840
35. Pettegrew, J. W., M. S. Keshavan, K. Panchulingam, S. Strychor, D. B. Kaplan, M. G. Tretta, M. Allen: Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. Arch. Gen. Psychiatry 48 (1991) 563-568
36. Schlossmacher, M. G., B. L. Ostaszewsld, L. I. Hecker, A Celi, C. Haass, D. Chin, I. Lieberburg, B. C. Furie, B. Furie, D. J. Selkoe: Detection of distinct isoform patterns of the β-amyloid precursor protein in human platelets and lymphocytes. Neurobiology of Aging 13 (1992) 421-434
37. 2: Isolation of the human gene and cDNA from porcine pancreas and human lung. DNA 5 (1986) 519-527
38. 2. J. Biol. Chem. 266 (1991) 14850-14853
39. Skinner, E. R., C. Watt, J. A O. Besson, P. V. Best: Lipid composition of different regions of the brain in patients with Alzheimer's disease. Biochem. Soc. Trans. 17 (1989) 213-214
40. Smith, R. P, D. A. Higuschi, G. J. Broze Jr.: Platelet coagulation factor Ixa-inhibitor, a form of Alzheimer amyloid precursor protein. Science 248 (1990) 1136-1128
41. 31P MR spectroscopy study of schizophrenics at different stages of illness. Proc. Soc. Magn. Reson. Med. 1 (1992) 756
42. 2 activity in senescent mouse. Neurochem. Res. 19 (1994) 317-320